Search results for "EU ORPHAN DRUG|Withdrawn|Treatment of beta thalassaemia intermedia and major" in comments (approximate match)
Showing 1 - 1 of 1 results
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Conditions:
Bitopertin is a Glycine transporter type 1 inhibitor which was developed by Hoffmann-La Roche for the treatment of patients with schizophrenia. The drug was shown to be potent in vitro, however it failed to meet primary endpoints in phase III. Bitope...